ID
33734
Description
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (1)
- 12/21/18 12/21/18 -
Copyright Holder
GSK group of companies
Uploaded on
December 21, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032
Period 1 Day 12 (Visit 100): Vital Signs, Pharmacodynamics, Drug Administration
Description
Study Drug Administration
Description
Was the dose administered?
Data type
boolean
Description
Dose Date
Data type
date
Description
Dose Time
Data type
time
Description
e.g., 0.5/0.35
Data type
text
Description
e.g., mg
Data type
text
Description
Comment
Data type
text
Description
Vital Signs
Description
Duplicate Number
Data type
integer
Description
Time
Data type
time
Description
Blood Pressure - Systolic
Data type
float
Measurement units
- mmHg
Description
Blood Pressure - Diastolic
Data type
float
Measurement units
- mmHg
Description
Heart Rate
Data type
integer
Measurement units
- bpm
Description
Temperature
Data type
float
Measurement units
- °C
Description
e.g., Sitting
Data type
text
Description
Comment
Data type
text
Description
Pharmacodynamic Blood Collection
No comments